NCT05095077View on ClinicalTrials.gov

Effects of Single Dose Tadalafil on Urethral and Anal Closure Function

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

January 1, 2022

Conditions
Urinary Incontinence,StressFecal Incontinence
Interventions
DRUG

Tadalafil 40 MG

Single dose on study day 1/2

DRUG

Placebo

Identical to active IMP

Trial Locations (1)

2400

Zelo Phase 1 unit, Copenhagen

All Listed Sponsors
lead

University Hospital Bispebjerg and Frederiksberg

OTHER

NCT05095077 - Effects of Single Dose Tadalafil on Urethral and Anal Closure Function | Biotech Hunter | Biotech Hunter